Trial · NCT00297115
Adverse events352
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 352
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Roflumilast | 64 | 778 | 71 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 23 | 790 | 25 |
| other | Weight decreased | Investigations | Roflumilast | 65 | 778 | 67 |
| other | Weight decreased | Investigations | Placebo | 20 | 790 | 20 |
| other | Nasopharyngitis | Infections and infestations | Roflumilast | 35 | 778 | 43 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 47 | 790 | 57 |
| serious | Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | Roflumilast | 87 | 778 | 110 |
| serious | Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | Placebo | 121 | 790 | 160 |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | Roflumilast | 4 | 778 | 4 |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | Placebo | 5 | 790 | 6 |
| serious | Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | Roflumilast | 2 | 778 | 2 |
| serious | Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | Placebo | 4 | 790 | 4 |
| serious | Bronchospasm | Respiratory, thoracic and mediastinal disorders | Roflumilast | 1 | 778 | 1 |
| serious | Bronchospasm | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 790 | 1 |
| serious | Hypoxia | Respiratory, thoracic and mediastinal disorders | Roflumilast | 0 | 778 | 0 |
| serious | Hypoxia | Respiratory, thoracic and mediastinal disorders | Placebo | 2 | 790 | 2 |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | Roflumilast | 0 | 778 | 0 |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | Placebo | 2 | 790 | 2 |
| serious | Respiratory arrest | Respiratory, thoracic and mediastinal disorders | Roflumilast | 1 | 778 | 1 |
| serious | Respiratory arrest | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 790 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00297115/events